Allan M Weinstein

US Patent:

6382205, May 7, 2002

Filed:

Nov 2, 1999

Appl. No.:

09/432133

Inventors:

Robert E. Weinstein - Boston MA 02116
Allan M. Weinstein - Potomac MD 20854

International Classification:

A61M 1100

US Classification:

12820023, 12820014, 12820312, 12820314, 206534, 206538, 206828

Abstract:

A method and device for organizing, storing, instructing, and coordinating the combined use of topical therapeutic agents, including moisturizing agents, for the treatment of respiratory tract disorders.

US Patent:

6447751, Sep 10, 2002

Filed:

Apr 18, 2001

Appl. No.:

09/837723

Inventors:

Robert E. Weinstein - Boston MA 02116
Allan M. Weinstein - Potomac MD 20854

International Classification:

A61K 912

US Classification:

424 45, 424 46, 424464, 424400

Abstract:

A dispensing container which incorporates an aerosolizable topical insulin preparation, at least one oral hypoglycemic agent, and indicia and instructions for their coordinated use as a single therapeutic regimen for the treatment of diabetes mellitus in a human, and a method for treating diabetes mellitus which employs such a device.

US Patent:

6514545, Feb 4, 2003

Filed:

Jan 25, 2001

Appl. No.:

09/769984

Inventors:

Robert E. Weinstein - Boston MA 02115
Allan M. Weinstein - Potomac MD 20854
David Schmier - Los Angeles CA 90025

International Classification:

A23L 200

US Classification:

426 87, 426 2, 426 74, 426108, 426120, 426590, 426656, 426658, 426810

Abstract:

A device and method for use in conjunction with exercise of about one hour or less which enhances convenience, and encourages compliance with a regimen of exercise beverages to accomplish preexercise hydration and postexercise hydration and muscle glycogen replenishment, and which includes a preexercise beverage formulation and a postexercise beverage formulation combined in a unified package with indicia and instructions. The preexercise beverage has a volume of from about 240 ml to about 300 ml, and the postexercise beverage has a volume of from about 300 ml to about 600 ml.

US Patent:

6521254, Feb 18, 2003

Filed:

Jan 10, 2001

Appl. No.:

09/757852

Inventors:

Robert E. Weinstein - Boston MA
Allan M. Weinstein - Potomac MD

Assignee:

J-Med Pharmaceuticals, Inc. - Boston MA

International Classification:

A61K 922

US Classification:

424468, 424400, 424439, 424465, 424466, 424464, 424488, 424489, 514159, 514224, 514335, 514290

Abstract:

Pharmaceutical dosage forms for oral administration of an antihistamine and a decongestant are disclosed. The dosage forms provide an antihistamine in an amount and formulation to exhibit antihistaminic activity in a human for greater than 22 hours; and a decongestant in an amount and formulation to exhibit stimulatory activity in a human for less than 16 hours. The formulation of the invention can be taken once per day to afford symptomatic relief of rhinitis while avoiding stimulation at night.

US Patent:

6652838, Nov 25, 2003

Filed:

Apr 4, 2002

Appl. No.:

10/115691

Inventors:

Robert E. Weinstein - Boston MA 02116
Allan M. Weinstein - Potomac MD 20854

International Classification:

A61K 912

US Classification:

424 45, 424 46, 424464, 424400, 12820014, 514866, 514 2

Abstract:

A method for treating postprandial hyperglycemia in diabetes mellitus in a human which employs a combination of an aerosolizable topical insulin and a short-acting oral hypoglycemic agent as a regimen taken adjacent to mealtime.

US Patent:

7156089, Jan 2, 2007

Filed:

Jun 11, 2003

Appl. No.:

10/461198

Inventors:

Robert E. Weinstein - Boston MA, US
Allan M. Weinstein - Potomac MD, US

International Classification:

A61M 11/00
A61L 9/04
B65D 85/42

US Classification:

12820019, 12820023, 424405, 206538

Abstract:

An organizational treatment device and method for the treatment of obstructive pulmonary disease comprising both controller and rescue medications such that the need for rescue medication and consequent need for controller medication can be more certainly determined than at present.

US Patent:

7233668, Jun 19, 2007

Filed:

May 23, 2002

Appl. No.:

10/155582

Inventors:

David J. Weinstein - Potomac MD, US
Allan M. Weinstein - Potomac MD, US
Paul A Kline - Gaithersburg MD, US
Jon L. Roberts - Great Falls VA, US

Assignee:

Sharestream, LLC - Washington DC

International Classification:

H04N 7/167
H04L 9/32

US Classification:

380201, 713189, 713193, 726 2

Abstract:

A system and method for securing intellectual property rights in distributed intellectual property. The present invention grants and polices rights in electronically distributed intellectual property. Use limitations are established by agreement by the content provider and the client. The use limitations are reflected in time-based, usage-based and player based component codes that are used to determine if the client is entitled to use the intellectual property. The present invention further protects the intellectual property from unauthorized use by encrypting the intellectual property with a key created from some or all of the component codes. As the component codes are known to both the client and the content provider, no key exchange is required by the present invention.

US Patent:

7749773, Jul 6, 2010

Filed:

Aug 3, 2007

Appl. No.:

11/833796

Inventors:

Alan R. Day - North Potomac MD, US
Allan M. Weinstein - Potomac MD, US
Bryan C. Christiansen - Germantown MD, US

International Classification:

G01N 33/53

US Classification:

436514, 436518, 436807, 436810, 435 4, 4352831, 4352877, 4352884

Abstract:

Disclosed is a test device and a method for qualitatively and/or quantitatively measuring the concentration of an analyte in a biological fluid sample. The test device includes a housing defining a sample port, a test well containing a stirrer and a conjugate, and a test strip disposed within the housing. The test well is also defined by being located between the sample port and the test strip. Fluid flows from the test well onto the test strip, which has a trapping zone which binds the analyte and allows for its detection. A control zone may also be included. The test device is generally adapted to use a sandwich assay. Also disclosed is a system comprising the test device and a signal sensing device; and a method for using the test device.